CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
Hyun Jin Kim, Seok O Park, Seung-Hyun Ko, Sang Youl Rhee, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Byung-Wan Lee, Jin Hwa Kim, Kyung Mook Choi,
Diabetes Metab J. 2017;41(6):423-429.   Published online December 19, 2017
DOI: https://doi.org/10.4093/dmj.2017.41.6.423

Excel Download

Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
Hyun Jin Kim
The Journal of Korean Diabetes. 2018;19(1):35   Crossref logo
Link1 Link2 Link3
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
Hyun Jin Kim, Seok O Park, Seung-Hyun Ko, Sang Youl Rhee, Kyu-Yeon Hur, Nan-Hee Kim, Min Kyong Moon, Byung-Wan Lee, Jin Hwa Kim, Kyung Mook Choi,
Diabetes & Metabolism Journal. 2017;41(6):423   Crossref logo
Link1 Link2 Link3
Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
Gagik R. Galstyan, Evgeniya A. Karataeva, Ekaterina A. Yudovich
Diabetes mellitus. 2017;20(4):286-298   Crossref logo
Link1 Link2
Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
Nina A. Petunina, Milena Е. Telnova
Diabetes mellitus. 2018;21(4):293-300   Crossref logo
Link1 Link2
Nephroprotective potential of glucagon-like peptide-1 receptor agonists
Minara S. Shamkhalova, Igor A. Sklyanik, Marina V. Shestakova
Diabetes mellitus. 2020;23(1):56-64   Crossref logo
Link1 Link2 Link3
Glucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
Deborah Hinnen
Diabetes Spectrum. 2017;30(3):202-210   Crossref logo
Link1 Link2
Emerging New Therapies for the Treatment of Type 2 Diabetes Mellitus: Glucagon-like Peptide-1 Receptor Agonists
Christopher A. Lindamood, James R. Taylor
Clinical Therapeutics. 2015;37(3):483-493   Crossref logo
Link1 Link2
Clinical Application of Glucagon-Like Peptide-1 Receptor Agonists
Se Hee Min, Young Min Cho
The Journal of Korean Diabetes. 2015;16(4):252   Crossref logo
Link1 Link2 Link3
Injectable Therapy for Diabetes Mellitus: Glucagon-Like Peptide-1 Receptor Agonist
Inkuk Lee, Eun Seok Kang
The Journal of Korean Diabetes. 2019;20(3):149   Crossref logo
Link1 Link2 Link3
Review of glucagon‐like peptide‐1 receptor agonists for the treatment of type 2 diabetes mellitus in patients with chronic kidney disease and their renal effects
Lance A. Sloan
Journal of Diabetes. 2019;11(12):938-948   Crossref logo
Link1 Link2 Link3